205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.66%
Net income growth above 1.5x MRVL's 1.60%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
6.25%
Some D&A expansion while MRVL is negative at -4.90%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-429.63%
Negative yoy deferred tax while MRVL stands at 2647.15%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
19.31%
Less working capital growth vs. MRVL's 88.28%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
917.24%
AR growth well above MRVL's 156.98%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-37.88%
Negative yoy inventory while MRVL is 94.78%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-59.76%
Negative yoy usage while MRVL is 68.13%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-633.33%
Negative yoy while MRVL is 86.33%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-6.68%
Negative yoy CFO while MRVL is 38.12%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
23.99%
Some CapEx rise while MRVL is negative at -267.73%. John Neff would see competitor possibly building capacity while we hold back expansions.
-137.29%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-16.25%
Negative yoy purchasing while MRVL stands at 11.01%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.63%
Below 50% of MRVL's 952.24%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
17.22%
Investing outflow well above MRVL's 29.31%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
600.00%
Stock issuance far above MRVL's 460.14%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.